ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy - 26/08/11
, Lars Wallentin, MD, PhD b, Tage Nilsson, MD, PhD c, Lott Bergstrand, MD, PhD d, Bertil Lindahl, MD, PhD b, Mikael Dellborg, MD, PhD aAbstract |
Background |
Evolution of the ST segment during ST-elevation myocardial infarction (STEMI) has been shown to yield more information on prognosis than widely used invasive measurements. With continuous ST monitoring, even very occasional dynamic changes can be analyzed. We have recently suggested that ST variability during the reperfusion-phase is of prognostic importance. We wanted to further investigate this and relate it to angiographic findings.
Methods |
A total of 177 patients with STEMI were examined in the ST-monitoring substudy of the ASessment of the Safety and Efficacy of a New Thrombolytic (ASSENT) PLUS trial, comparing dalteparin with heparin as adjunctive therapy to t-PA. Patients underwent 24 hours of ST monitoring. These recordings were blindly analyzed by 2 independent observers. A coronary angiogram was performed on days 4 to 7, also blindly evaluated by 2 persons.
Results |
Occurrence of ST re-elevations during and after the reperfusion-phase was significantly associated with residual thrombi and TIMI-flow in the infarct-related artery. Patients without any ST re-elevations showed a thrombus in only 5% of cases, as compared with 86% of patients with prolonged (lasting >30 minutes) ST re-elevations. In a multivariate comparison including baseline-data and treatment, most information on persistence of thrombi was contributed by the presence of any ST re-elevations (odds ratio, 5.8; 95% CI, 1.3–26).
Conclusion |
ST re-elevations during the first day of an acute myocardial infarction are associated with residual thrombi in the infarct-related artery even 4 to 7 days after the STEMI.
Le texte complet de cet article est disponible en PDF.Plan
 | Supported by research grants from the Swedish Heart and Lung Foundation, Stockholm, Sweden, Ortivus AB, Täby, Sweden, University of Göteborg, Göteborg, Sweden, Boehringer Ingelheim, Skärholmen, Sweden, and Pharmacia Upjohn, Sweden. |
Vol 147 - N° 5
P. 853-858 - mai 2004 Retour au numéro
Article précédent
- Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction
- C.Michael Gibson, Juhana Karha, Robert P Giugliano, Mathew T Roe, Sabina A Murphy, Robert A Harrington, Cindy L Green, Marc J Schweiger, Jerry S Miklin, Kenneth W Baran, Sebastian Palmeri, Eugene Braunwald, Mitchell W Krucoff, INTEGRITI Study Group
- Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines?
- Moti Haim, Alexander Battler, Solomon Behar, Paolo M Fioretti, Valentina Boyko, Maarten L Simoons, David Hasdai
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?